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Abstract
Background: The increased resistance of hypoxic cells to ionizing radiation is usually believed to be the primary
reason for treatment failure in tumors with oxygen-deficient areas. This oxygen effect can be expressed
quantitatively by the oxygen enhancement ratio (OER). Here we investigate theoretically the dependence of the
OER on the applied local dose for different types of ionizing irradiation and discuss its importance for clinical
applications in radiotherapy for two scenarios: small dose variations during hypoxia-based dose painting and larger
dose changes introduced by altered fractionation schemes.
Methods: Using the widespread Alper-Howard-Flanders and standard linear-quadratic (LQ) models, OER
calculations are performed for T1 human kidney and V79 Chinese hamster cells for various dose levels and various
hypoxic oxygen partial pressures (pO2) between 0.01 and 20 mmHg as present in clinical situations in vivo. Our
work comprises the analysis for both low linear energy transfer (LET) treatment with photons or protons and high-
LET treatment with heavy ions. A detailed analysis of experimental data from the literature with respect to the
dose dependence of the oxygen effect is performed, revealing controversial opinions whether the OER increases,
decreases or stays constant with dose.
Results: The behavior of the OER with dose per fraction depends primarily on the ratios of the LQ parameters
alpha and beta under hypoxic and aerobic conditions, which themselves depend on LET, pO2 and the cell or
tissue type. According to our calculations, the OER variations with dose in vivo for low-LET treatments are
moderate, with changes in the OER up to 11% for dose painting (1 or 3 Gy per fraction compared to 2 Gy) and up
to 22% in hyper-/hypofractionation (0.5 or 20 Gy per fraction compared to 2 Gy) for oxygen tensions between 0.2
and 20 mmHg typically measured clinically in hypoxic tumors. For extremely hypoxic cells (0.01 mmHg), the dose
dependence of the OER becomes more pronounced (up to 36%). For high LET, OER variations up to 4% for the
whole range of oxygen tensions between 0.01 and 20 mmHg were found, which were much smaller than for low
LET.
Conclusions: The formalism presented in this paper can be used for various tissue and radiation types to estimate
OER variations with dose and help to decide in clinical practice whether some dose changes in dose painting or in
fractionation can bring more benefit in terms of the OER in the treatment of a specific hypoxic tumor.
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The poor treatment prognosis for tumors with oxygen-
deficient areas is usually attributed to the decreased
radiosensitivity of hypoxic cells. Hypoxia has been iden-
tified in many tumor types and the disadvantageous
impact of hypoxia on local tumor control has been well
recognized [1-4]. Due to the rapid development of non-
invasive imaging methods to estimate the spatial distri-
bution of the oxygen partial pressure within the tumor
using different hypoxia markers [5-7], patient-specific
treatment planning using dose painting or dose escala-
tion in multifraction regimes based on functional
hypoxia imaging is now considered a promising
approach to overcome hypoxia in radiotherapy [8,9].
The radioprotective effect of hypoxia can be expressed
quantitatively by the oxygen enhancement ratio (OER),
which is defined as the ratio of doses D(p1) and D(p2)
given under two different oxygenation conditions with
oxygen partial pressures p1≤p2 to produce the same bio-
logical effect. Depending on the interest of the researcher,
the comparison can be done between hypoxic-aerobic,
anoxic-hypoxic, aerobic-hypobaric etc. conditions. His-
torically the OER has been defined as the radiation dose
under anoxic conditions (p1 = 0 mmHg = const) divided
by the dose under conditions of some partial pressure of
oxygen p2 =p . In this way, the OER typically increases
from unity at anoxic conditions to approximately 3 for
normoxic conditions in vitro. Alternatively, OER is often
stated as the ratio of the dose to hypoxic cells (at differ-
ent levels of p1 = p) to the dose to aerobic cells (usually
in air, p2 = 160 mmHg = const). In this case the OER
decreases with increasing oxygen partial pressure in the
cell environment, and the term hypoxia reduction factor
(HRF) is sometimes used instead of OER here. In this
paper, we employ the most general definition of OER
with variable p1 and p2 at the same time.
It has been observed that the OER depends on many fac-
tors such as the oxygen partial pressures (pO2)f o rh y p o x i c
and aerobic conditions, the tissue type, the linear energy
transfer (LET) of the radiation and the chosen cell survival
level (or alternatively the applied local dose). In this work
we focus on the dose dependence of the OER and investi-
gate if and how this dependence is important for clinical
applications in radiotherapy. To open the discussion we
review the experimental data of the dose dependence of
the OER published from 1975 up to 2010. In contrary to
the relative biological effectiveness (RBE), which was
observed to decrease with increasing dose per fraction
independent of radiation type and cell line, no clear ten-
dency for the dose dependence of the OER (decreasing,
increasing or constant) was reported in the literature.
The purpose of this paper is to estimate the amount
of potential OER variations with dose in low- and high-
LET radiotherapy and to assess the potential impact for
clinical applications. Based on the previously developed
OER model [10] and parameters for several tissue types,
we will evaluate two clinically relevant scenarios: the
first scenario deals with dose painting strategies, where
an inhomogeneous dose within the target volume
according to the oxygenation status is prescribed. Typi-
cally this involves relatively small local changes of the
dose in the order of ± 50% of the mean dose per frac-
tion. The second scenario considers much larger
changes in the dose per fraction which occur if the
overall fractionation scheme is modified (hyper- or
hypofractionation).
Methods
The survival of cells after exposure to a radiation dose is
often described by the linear-quadratic (LQ) model [11].
This model is now in widespread use in both experi-
mental and clinical radiobiology and generally works
well in reproducing experimental results both in vitro
and in vivo. We employed the standard LQ model with
its two radiosensitivity parameters a and b in its most
simplified form (without reoxygenation between frac-
tions). Dose rate effects [12,13] were also not taken into
account.
In this simplified case the fraction S of cells that sur-
vive an applied dose D may be written as:
S = exp(−αD − βD2) (1)
The applied dose has to be changed to achieve the
same biological effect under different irradiation condi-
tions (e.g. high vs. low LET, aerobic vs. hypoxic environ-
ment etc.). This can be expressed by an enhancement
factor (EF) defined as the ratio of doses given to a biolo-
gical system under two different conditions, where the
dose applied under the first condition 1 must be modi-
fied compared to the dose applied under the second
condition 2 to obtain the same cell survival level:
EF =
D1
D2
 
 
S=const
(2)
Due to the nonlinear form of the initial shoulder of
the survival curves, the EF can vary depending on the
choice of the specific survival level used as endpoint.
This means the EF depends on the applied local dose
(Figure 1A). When comparing low- and high-LET radia-
tion (e.g. x-rays and carbon ion beams), this enhance-
ment factor is called RBE and Eq. 1 can be written as:
RBE =
Dx−rays
Dcarbon
 
 
S=const
(3)
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oxygenation conditions (p1 and p2, with p1≤p2), this fac-
tor defines the OER:
OER =
D(p1)
D(p2)
 
 
S=const
(4)
It was observed in the vast majority of experiments
using various cell lines/tissue types and various radiation
types that the RBE decreases with increasing dose per
fraction (e.g. [14,15]), see Figure 1B for a typical
example. The reason is that the x-ray survival curve
usually has a relatively largei n i t i a ls h o u l d e r ,w h e r e a s
the shoulder for high-LET radiation is usually smaller
and the initial slope steeper (larger a value). For the
OER, the situation is more complex. Depending on the
cell line and the radiation type, some investigators
found an increasing, some a decreasing and others a
constant OER with increasing dose (see Figure 1B, and a
list of relevant experimental studies in Tables 1 and 2),
and the changes in the shape of the survival curves are
quite variable. Table 2 adds experimental OER studies
for high LET, which was here limited to the range 80-
120 keV/μm.
By equating the LQ-predicted surviving fractions (Eq.
1) for cells irradiated under aerobic (a)a n dh y p o x i c( h)
conditions
S(Da)=S(Dh)
exp(−αaDa − βaD2
a) = exp(−αhDh − βhD2
h)
(5)
a n du s i n gE q .4o n eo b t a i n sas i m p l ef o r m u l af o rt h e
OER depending on dose Dh given to hypoxic cells
(which needs to be the dose per fraction in a multifrac-
tion regime) and on tissue specific parameters aa, ah, ba
and bh:
OER(Dh,αa,βa,αh,βh)=2 Dhβa


α2
a +4 βa(αhDh + βhD2
h) − αa
 (6)
In the limit of very small doses per fraction (Dh®0),
t h eO E Ri sg i v e nb yt h er a t i oaa/ah,w h e r e a sf o rv e r y
large doses per fraction (Dh®∞), OER is determined by
the b parameters only:
OER(Dh → 0) =
αa
αh
OER(Dh →∞ )=

βa
βh
(7)
Since the first derivative of OER with respect to D
never vanishes for D > 0 (unless aa/ah =( ba/bh)
1/2), the
OER increases with dose per fraction if the ratio aa/ah
is smaller than (ba/bh)
1/2 for a specific cell line, and
decreases with dose for aa/ah >( ba/bh)
1/2.I nt h ec a s e
of aa/ah =( ba/bh)
1/2, the OER is independent of dose.
In contrast to the RBE, where the ratio of the a values
is typically much larger than the square root of the ratio
of the b values (leading to a decreasing RBE with dose),
these ratios show larger variability for the OER.
Obviously, the OER depends not only on dose and tis-
sue type but also on LET and pO2.B a s e do nE q .6w e
assume that these dependences are determined by the
LQ parameters a(LET, pO2)a n db(LET, pO2). The
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Figure 1 Dose dependence of Survival and Enhancement
Factor. Panel A: Schematic illustration of the dependence of the
enhancement factor (EF) on survival level and on dose. Panel B:
Representative examples of the dose dependence of the EF: RBE
(dashed-dotted line) and OER (solid lines) as a function of dose for
high-LET radiation with argon ions (OERAr) and low-LET radiation
with x-rays (OERX) calculated using experimental data for V79
Chinese hamster cells in vitro. The OER curves were obtained using
Eq. 6 and the experimental data for LQ parameters aa, ah, ba and
bh from [26] (OERAr, OERX1), [27] (OERX2) and [28] (OERX3). The RBE
was calculated according to [29] using parameters aa and ba for
argon ions and x-rays from [26].
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model that we presented previously [10]. Briefly, our
model is based on the experimental data from the litera-
ture. For an analysis of these data in order to obtain the
dependence of the LQ parameters a and b on pO2 we
used (like many other investigators [6,16,17]) the con-
cept of Relative Radiosensitivity (RR) according to the
Alper and Howard-Flanders model [18]. The RR
describes the response of a biological system to radia-
tion dependent on oxygen tension p in the cell environ-
ment. RR is maximized at high oxygen concentrations
and approaches unity for low oxygen levels:
RR(p)=
m · p +1· K
p + K
(8)
Here m is the maximum radiosensitivity and K is the
oxygen concentration at which the RR equals half of its
maximum. Based on this concept we assume an Alper-
Howard-Flanders dependence of a(p)a n db
1/2(p)o n
pO2. These functions have a similar shape as the relative
radiosensitivity, although the maxima and minima are
different. Furthermore, we suggest in the clinically rele-
vant LET region (where the RBE increases with LET) a
simple linear dependence of a on LET and suppose b to
be independent of LET (the dependence of b on LET
w a sa l s od i s c u s s e di n[ 1 0 ] ) .T a k i n gt h ep O 2 and LET
dependence together, one obtains:
α(L,p)=
(a1 + a2 · L) · p +( a3 + a4 · L) · K
p + K

β(L,p)=

β(p)=
b1 · p + b2 · K
p + K
(9)
where L is LET and a1,a 2,a 3,a 4,b 1,a n db 2 are con-
stant coefficients that were estimated by fitting the
experimental data in vitro from the literature [10].
Finally, equation (6) can be written as:
OER(Dh,L,pa,ph)=2 Dhβ(L,pa)


α2(L,pa)+4 β(L,pa)(α(L,ph)Dh + β(L,ph)D2
h) − α(L,pa)
 (10)
with oxygen partial pressures pa and ph under hypoxic
and aerobic conditions (ph≤pa). As mentioned in Back-
ground these oxygen partial pressures are two
Table 1 Summary of references to published mammalian
cell survival data measured in experiments at low LET
Ref. Cells Rad. type (LET) aa/ah (ba/bh)
1/2 OER(D)
[30] V79-379A x-rays 1.4 3.8 ↗
[31] V79-379A x-rays 2.0 3.6 ↗
[32] V79-753B x-rays 3.9 2.8 ↘
[25] V79-379A x-rays ®
[33] V79-B x-rays ↗
[28] V79-171 x-rays 2.3 3.6 ↗
[26] V79 protons (0.7 keV/μm) 1.7 4.5 ↗
V79 protons (1.9 keV/μm) 1.9 3.2 ↗
V79 x-rays 3.6 2.5 ↘
[34] V79 x-rays ↘
[27] V79 x-rays 3.2 3.1 ®
[33] V79 x-rays ®
CHO-6 x-rays ®
[35] CHO-K1
60Co g-rays ↗
CHO-xrs6
60Co g-rays ↗
[36] CHO-K1 x-rays ↗
[37] CHL-F
60Co g-rays ®
[38] R1 x-rays ®
[39] R1 x-rays ®
[40] FSa-II
60Co g-rays 1.6 2.8 ↗
FSa-II protons (1.9 keV/μm) 1.9 2.6 ↗
[41] T1 x-rays 5.0 2.3 ↘
[33] AA8 x-rays ↘
[42] EMT6
60Co g-rays ↗
[43] B14 FAF28
60Co g-rays ↘
[44] U251
60Co g-rays 4.0 2.5 ↘
For each reference the cell line, the radiation type, the ratios of the
radiosensitivity parameters (if provided) under aerobic (a) and hypoxic (h)
conditions and the OER behavior as a function of dose (↗ increases, ↘
decreases or ® remains nearly constant with increasing single dose) are
given. The low-LET range was chosen between 0.2 and 2 keV/μm.
Table 2 Summary of references to published mammalian
cell survival data measured in experiments at high LET
Ref. Cells Rad. type LET (keV/μm) aa/ah (ba/bh)
1/2 OER(D)
[26] V79 argon 94 1.5 3.4 ↗
[45]* V79 carbon 102 2.7 1.1 ↘
V79 neon 110 2.0 1.3 ↘
HSG carbon 88 2.2 1.3 ↘
HSG neon 84 2.9 1.6 ↘
[38] R1 a-particles 110 ®
[39] R1 carbon 95 ®
[46] R1 carbon 90 2.0 1.6 ↘
R1 carbon 95 1.8 1.7 ®
R1 neon 90 1.4 1.9 ↗
R1 neon 120 1.7 1.5 ®
R1 argon 95 2.1 1.3 ↘
[41] T1 carbon 85 2.7 1.4 ↘
T1 neon 100 1.8 2.9 ↗
T1 argon 81 2.3 2.4 ®
T1 argon 91 2.0 2.5 ↗
T1 argon 117 1.7 1.7 ®
[44] U251 8 keV x-rays > 50 1.3 > 2.9 ↗
*Because of the large amount of the data in this reference for the LET range
between 80 and 120 keV/μm, only a few representative cases are listed here
to demonstrate the OER behavior.
For each reference the cell line, the ion beam type, the LET, the ratios of the
radiosensitivity parameters (if provided) under aerobic (a) and hypoxic (h)
conditions and the OER behavior as a function of dose (↗ increases, ↘
decreases or ® remains nearly constant with increasing single dose) are
given. The high-LET range was chosen between 80 and 120 keV/μm.
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depends on the choice of both of them. Equation (10)
can be used to describe the OER for different radiation
types (low-LET and high-LET) and for various oxygen
levels relevant for cell experiments in vitro and clinical
situations in vivo. This OER model is a simple tool to
quantify the oxygen effect in a practical way. The results
of our model for the dependence of OER on LET and
pO2 as discussed in our previous paper are in good
agreement with preclinical and clinical studies [10].
In this paper we deal with the dependence of OER on
dose per fraction for different irradiation types and
degrees of hypoxia. The OER calculations were done for
two cell types (V79 Chinese hamster cells and T1
human kidney cells) because only for these cell lines
there was sufficient experimental data both in the low-
and high-LET area (Tables 1 and 2). For low LET (0.2-2
keV/μm), the mean values of a and b found in the lit-
erature were taken (V79: aa = 0.135 Gy
-1, ba =0 . 0 3 2
Gy
-2, ah = 0.06 Gy
-1, bh = 0.003 Gy
-2;T 1 :aa =0 . 1 0G y
-
1, ba = 0.047 Gy
-2, ah = 0.02 Gy
-1, bh = 0.009 Gy
-2). The
values for V79 are similar to the data used by Carlson et
al. [19] in an OER modeling study for prostate cancer
and might therefore be relevant for clinical applications
as well. The tissue parameters for high LET were esti-
mated by an LET-dependent fitting of the aerobic and
hypoxic experimental data in vitro for a and b in the
full high-LET region between 10 and 260 keV/μm[ 1 0 ]
to determine the parameters at 100 keV/μm( V 7 9 :aa =
0.75 Gy
-1, ba = 0.061 Gy
-2, ah =0 . 4 1G y
-1, bh = 0.014
Gy
-2;T 1 :aa =0 . 6 2G y
-1, ba = 0.067 Gy
-2, ah =0 . 3 5G y
-
1, bh = 0.019 Gy
-2).
Results
OER values as a function of dose for V79 and T1 cells
are shown in Figure 2 for low LET = 1 keV/μm (the
middle of the range between 0.2 and 2 keV/μm) and
high LET = 100 keV/μm (the middle of the range
between 80 and 120 keV/μm). At low LET, OER is
given for doses up to 20 Gy per fraction, whereas for
high LET the physical absorbed dose is typically lower
(due to the RBE), and the relevant dose is set up to 10
Gy per fraction. Of course, the predictions of the LQ
model for high doses should be taken with great care.
This model is well validated, both experimentally and
theoretically, up to doses per fraction of about 10 Gy,
and may be applicable to higher doses as well [20].
For V79 cells, the OER increases with dose at low and
high LET, whereas it decreases with dose for T1 cells at
low LET and stays almost constant for high LET. The
dashed lines in Figure 2 show the OER for a typical cell
experiment in vitro under extreme hypoxia (ph =0 . 0 1
mmHg, pa = 160 mmHg). The ratios of the employed
LQ parameters in vitro under hypoxic and aerobic
conditions, which determine how and how strong the
OER changes with increasing dose per fraction, were
aa/ah =2 . 2 5 ,( ba/bh)
1/2 =3 . 2 7( V 7 9c e l l s )a n daa/ah =
5.0, (ba/bh)
1/2 = 2.29 (T1 cells) at low LET and aa/ah =
1.83, (ba/bh)
1/2 = 2.09 (V79) and aa/ah = 1.77, (ba/bh)
1/2
= 1.88 (T1) at high LET. They can be compared with
the ratios listed in Tables 1 and 2. If for example the
value aa/ah for some experiment from Table 1 or 2 is
lower than the value given above for V79 and the value
(ba/bh)
1/2 higher as above for the same cell line and
LET range, the curves of the dose dependence of OER
will be steeper than in Figure 2 and the dose depen-
dence is more pronounced.
To make the situation clinically more realistic, OER is
also calculated for a set of hypoxic oxygen partial pres-
sures ph between 0.2 and 20 mmHg, whereas pa =3 0
mmHg is referred to as aerobic (well oxygenated cells in
vivo) [15,21]. Since typical threshold values for the
tumor oxygenation status in clinical and preclinical
practice to estimate the treatment outcome of patients
with a hypoxic tumor are < 2.5 mmHg, < 5 mmHg, <
10 mmHg and < 20 mmHg (see also Discussion in [10]),
we calculated the dose dependence of the OER for these
pO2 levels (solid lines in Figure 2). Because of the prop-
erties of clinically used Eppendorf histographs it is not
possible to determine pO2 values for extreme hypoxia
[22]. The lowest median pO2 values measured experi-
mentally with Eppendorf histographs are typically 0.2
mmHg [6,23]. Figure 2 shows our calculation also for
this oxygen level. Of course, cells at much lower oxygen
concentrations can exist within a tumor and contribute
to treatment failure. As a “worst case approximation”,
we also calculated the dependence of OER on dose for
such extreme hypoxic cells in vivo (ph = 0.01 mmHg, pa
= 30 mmHg). The OER values relevant for two scenar-
ios of clinical dose variations are detailed in Table 3.
For scenario 1 (dose painting), a mean dose per fraction
of 2 Gy (low LET) or 1 Gy (high LET) is assumed as
the baseline, and the OERs for ± 50% of this dose are
given (which can be considered as extreme values for
the dose variation within the target volume). For sce-
nario 2 (hyper-/hypofractionation), the same baseline is
used and OERs at one fourth (extreme hyperfractiona-
tion) and ten times the baseline (extreme hypofractiona-
tion) are evaluated. The values in Table 3 are calculated
for a low, but still clinically measurable value of ph = 0.2
mmHg. The higher the oxygen partial pressure in a
tumor, the less pronounced will be the variations of the
OER with changing dose per fraction. For extremely
hypoxic cells within a tumor, these variations could be
more distinct (see Figure 2). For ph = 0.01 mmHg and
pa = 30 mmHg, the changes in OER amount up to 6%
(19%) for V79 und 26% (36%) for T1 cells if the dose
p e rf r a c t i o ni sv a r i e df r o m2t o0 . 5G y( 2 0G y )f o rl o w -
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extreme hypoxia are comparable with the changes at ph
= 0.2 mmHg (Table 3).
Discussion
In previous modelling studies regarding the OER
[6,16,17,24,25], both dose-independent and dose-depen-
dent implementations of the OER were used, mostly
based on the Alper-Howard-Flanders formula of relative
radiosensitivity (Eq. 8) or some modifications of this
equation. With respect to experimental data published
in the literature, decreasing, increasing and constant
OERs with increasing dose for various cell lines and var-
ious radiation types were reported (Tables 1 and 2).
Corresponding to our calculation in the framework of
the LQ model, the OER depends on dose and its
behavior is determined by the ratios of the LQ para-
meters aa/ah and (ba/bh)
1/2 under aerobic and hypoxic
conditions (Eq. 7). Since these ratios can vary consider-
ably with tissue/cell type, LET and pO2 (at least experi-
mentally), this could explain the controversial findings
from the publications in Tables 1 and 2. Only if these
ratios are equal, the dose dependence disappears. This
can be implemented on the modelling side if the pO2
dependence of a and b is given by a(p)= aa/f(p)a n db
(p)=ba/f(p)
2 (with the same function f(p) for both a
and b) as used by Malinen et al.[ 6 ]o rC a r l s o net al.
[25]. One can argue whether or not this special case is
actually realized in all cell lines or tissue types [25] (at
least within experimental uncertainties), and whether a
mechanistic interpretation of the LQ parameters and the
underlying microscopic processes of radiation damage
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Figure 2 Dose dependence of OER for V79 and T1 cells. Dependence of OER on dose per fraction given to hypoxic cells for V79 (Panels A
and B) and T1 cell lines (Panels C and D) at low-LET (Panels A and C) and high-LET (B and D). Solid lines show the model calculations for
oxygen partial pressures ph in vivo between 0.01 and 20 mmHg (pa = 30 mmHg). Dashed lines correspond to cell experiments in vitro under
extreme hypoxia (ph = 0.01 mmHg, pa = 160 mmHg).
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of mechanistic interpretations in radiation biology and
the relatively large experimental error bars, a dose
dependence of the OER can certainly not be excluded,
which motivated us to study the potential clinical
impact of a dose dependent OER.
The calculations performed in this work can be used
to estimate - for a certain cell line or tissue type, irradia-
tion type and oxygenation condition - whether, how and
with which magnitude the OER varies with dose.
Although the underlying OER model [10] used here was
primarily based on experimental data from the literature
in vitro, due to the implemented Alper-Howard-Flanders
concept it can also provide reasonable predictions for
preclinical and clinical situations in vivo (as discussed in
detail in [10]). We therefore conclude that our analysis
of the dependence of OER on dose per fraction has also
some value for the assessment of realistic clinical situa-
tions, at least qualitatively.
Our investigation of the oxygen effect at clinically
measured median oxygen tensions ph between 0.2 and
20 mmHg shows a relatively moderate dependence of
the OER on dose per fraction (Table 3). The higher the
oxygen partial pressure in a tumor, the less pronounced
is the variation of the OER with dose (Figure 2). For
hypoxia-based dose painting in the target volume (sce-
nario 1, with local dose variations in the target between
1 and 3 Gy for low LET), the changes of the local OER
in vivo were below ± 11% relative to the baseline of 2
Gy per fraction (Table 3). For high LET (dose variations
between 0.5 and 1.5 Gy), these variations were much
smaller (up to 1%). If the dose per fraction is varied
over a larger range (by changing the fractionation
scheme, scenario 2), OER variations in the order of ±
21% (0.5 Gy vs. 2 Gy per fraction) and ± 22% (20 Gy vs.
2 Gy per fraction) can be seen for low LET. Again, this
was much smaller for high LET (up to 1% difference in
OER for 0.25 Gy vs. 1 Gy and up to 4% for 10 Gy vs. 1
Gy per fraction). For a potential portion of extremely
h y p o x i cc e l l sw i t h i nat u m o rt h ed o s ed e p e n d e n c eo f
the OER becomes more pronounced in low-LET
treatment (see Results), but stays still moderate for high
LET. One has to note that the values above depend
strongly on the oxygenation conditions and tissue types,
and the direction and magnitude of the OER variation
could differ from the OERs for V79 and T1 cell lines.
Nevertheless, the formalism presented in this paper can
be used to estimate OER variations with dose and help
to decide in clinical practice whether some changes in
fractionation (hyper- or hypofractionation) can bring
more benefit in the treatment of patients with a specific
hypoxic tumor. For example, for human salivary gland
(HSG) tumor cells the OER decreases with increasing
dose under high-LET irradiation (Table 2). This means
that a hypofractionated treatment in high-LET radio-
therapy with heavy ions could be more advantageous
with respect to the oxygen effect for patients with this
kind of tumor. However, this can only be confirmed by
clinical studies using high LET and various fractionation
schemes, which (to the best of our knowledge) are cur-
rently not available for this tumor type. Alternatively,
small animal experiments with implanted human tumors
(which often exhibit large hypoxic fractions) could be a
means to evaluate the impact of OER for various frac-
tions schemes in a pre-clinical setting, and to validate
the findings of our modeling study.
Another example can be based on the data published
by Malinen et al. [6]. The authors investigated a sponta-
neous sarcoma of a dog with different hypoxic com-
pounds within the tumor. In the most hypoxic area the
measured average oxygen partial pressure ph was 0.2
mmHg. Using their data we calculated for this pO2
value aa/ah =1 . 7 5a n d( ba/bh)
1/2 =3 . 2 5( E q .4a n d
Table 1 in [6]). Compared with our analysis for V79 cell
line under low-LET irradiation (aa/ah =2 . 2 5a n d( ba/
bh)
1/2 = 3.27 and Figure 2A) the dependence of OER on
dose per fraction for sarcomas from the study by Mali-
nen et al. is also relatively moderate. The higher the
oxygen partial pressure in a tumor, the less significant is
the variation in the OER with the choice of dose per
fraction. However, if hypoxia based treatment planning
shall be performed, a larger number of fractions with
Table 3 OER variations with dose per fraction
Low LET (1 keV/μm) High LET (100 keV/μm)
Dose (Gy) OER Dose (Gy) OER
V79 T1 V79 T1
Baseline 2.0 2.16 2.74 1.0 1.70 1.66
Scenario 1 1.0 2.09 (-3%) 3.05 (+11%) 0.5 1.69 (-1%) 1.66 (0%)
(dose painting) 3.0 2.21 (+2%) 2.57 (-6%) 1.5 1.70 (0%) 1.66 (0%)
Scenario 2 0.5 2.05 (-5%) 3.32 (+21%) 0.25 1.69 (-1%) 1.66 (+0%)
(hyper-/hypo-fractionation) 20 2.52 (+17%) 2.14 (-22%) 10 1.77 (+4%) 1.68 (+1%)
The calculations were performed for V79 and T1 cell lines irradiated at ph = 0.2 mmHg with various dose levels. OER values (with respect to pa = 30 mmHg) are
given for the baseline as well as for two scenarios of dose painting and hyper- or hypofractionation, along with the relative differences to the baseline situation
(in percent).
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Page 7 of 9smaller doses (hyperfractionation) could - due to the
increasing OER with dose - bring more benefit with
respect to the oxygen effect for the treatment of the sar-
coma presented by Malinen et al. [6].
Although the OER seems to be only moderately
dependent on the choice of dose per fraction, tumor
hypoxia itself has a large negative effect on cell killing
and there is potential for large errors in calculation of
alternative dose fractionation schemas using models
that do not account for tumor hypoxia at all [19], even
i ft h ed o s ed e p e n d e n c ei sn o tconsidered explicitly. In
the case where measurements of oxygen partial pres-
sures in a tumor are possible (e.g. with an Eppendorf
histograph or noninvasive methods), the additional
dose to hypoxic areas of the tumor required to achieve
a constant biological effect in the whole target can be
calculated in the framework of our model (Eq. 10) for
various radiation types, oxygen tensions and tissue
types. In the long run, this may help to overcome the
adverse effects of low oxygen concentrations in many
tumors.
Conclusions
Since tumors with hypoxic areas exist and the treatment
outcome of patients with hypoxic tumors is relatively
poor, new predictive models are required to individua-
lize and improve the treatment strategies for radiother-
apy. In this work we investigated theoretically the
importance of the dose dependence of the OER for clin-
ical applications in radiotherapy. The analysis was per-
formed for two scenarios: small dose variations within
the target during dose painting and larger changes of
the dose per fraction for different fractionation schemes.
The calculations were performed for both low-LET
treatment with photons or protons and high-LET treat-
ment with heavy ions.
According to our analysis, the OER in clinical prac-
tice is moderately sensitive to the choice of dose per
fraction. The OER can increase, decrease or remain a
constant with increasing dose per fraction, and this
behavior is determined by the ratios of the LQ para-
meters under hypoxic and aerobic conditions. These
effects should be taken into account in hypoxia based
treatment plan optimization. The formalism presented
in this paper can be used to estimate OER variations
with dose and to help with clinical decisions about any
changes in dose prescription or treatment planning
with respect to the oxygen effect. If simplified models
without explicit consideration of the dose dependence
are used for optimization in dose painting or changes
of the fractionation scheme, our methods can be used
to estimate the potential error in OER due to dose
variations.
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